Up a level |
Hykin, Philip, Prevost, A Toby, Vasconcelos, Joana C, Murphy, Caroline, Kelly, Joanna, Ramu, Jayashree, Hounsome, Barry, Yang, Yit, Harding, Simon P ORCID: 0000-0003-4676-1158, Lotery, Andrew et al (show 63 more authors)
(2019)
Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion A Randomized Clinical Trial.
JAMA OPHTHALMOLOGY, 137 (11).
pp. 1256-1264.
Hykin, Philip, Prevost, A Toby, Sivaprasad, Sobha, Vasconcelos, Joana C, Murphy, Caroline, Kelly, Joanna, Ramu, Jayashree, Alshreef, Abualbishr, Flight, Laura, Pennington, Rebekah et al (show 9 more authors)
(2021)
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.
HEALTH TECHNOLOGY ASSESSMENT, 25 (38).
1-+.
Peto, Tunde, Evans, Rebecca N, Reeves, Barnaby C, Harding, Simon ORCID: 0000-0003-4676-1158, Madhusudhan, Savita, Lotery, Andrew, Downes, Susan, Balaskas, Konstantinos, Bailey, Clare C, Foss, Alexander et al (show 7 more authors)
(2022)
Long-term Retinal Morphology and Functional Associations in Treated Neovascular Age-Related Macular Degeneration.
OPHTHALMOLOGY RETINA, 6 (8).
pp. 664-675.
Pearce, Ian, Amoaku, Winfried, Bailey, Clare, Downey, Louise, Gale, Richard, Ghanchi, Faruque, Hamilton, Robin, Mahmood, Sajjad, Menon, Geeta, Nosek, Jenny et al (show 2 more authors)
(2022)
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice.
EYE, 36 (9).
pp. 1725-1734.